Prenatal Next Karyo Full Test: All Chromosomes + Sex Chromosomes + Deletions and Microdeletions + Gender + Hereditary and Non-Hereditary Diseases in the Baby + 30 Hereditary Diseases in the Parents

At IntroLab in Belgrade, the advanced genetic test called the Next Karyo Full test is available, using the latest NGS technology. This test offers a comprehensive analysis of all chromosomes, including sex chromosomes, and allows for the detection of deletions, microdeletions, as well as determining the baby’s gender.

What is the prenatal Next Karyo Full test?

The Next Karyo Full test is a comprehensive genetic analysis that includes:

• Analysis of all chromosomes: The test examines all 23 pairs of chromosomes, including the X and Y chromosomes, allowing for the identification of a wide range of genetic disorders and abnormalities.
• Detection of deletions and microdeletions: This test can detect deletions and very small deletions (microdeletions) in genetic material, which may lead to serious genetic disorders.
• Determination of fetal gender: By analyzing the sex chromosomes, the test can also determine the baby’s gender, which can be important in cases where gender-related genetic diseases are a concern.
• Analysis of hereditary and non-hereditary diseases in the baby: In addition to chromosomal analysis, the test can identify genetic markers associated with hereditary and non-hereditary diseases in the baby.
• Screening for up to 30 hereditary diseases in the parents: Analyzing the parents’ genetic predispositions helps assess the risk of passing certain genetic diseases to their offspring.

The importance of the Next Karyo Full test

This test is crucial as it enables the early detection of genetic disorders that may affect the child’s health. Understanding the genetic status can assist in making informed decisions about pregnancy, prenatal care, and planning for the child’s future health and care. By testing both parents for genetic mutations, the risk of hereditary diseases can be assessed, improving genetic counseling and family planning.

Who is the prenatal Next Karyo Full test for?

The Next Karyo Full test is especially beneficial for:

• Couples planning a pregnancy: This test can help assess genetic risks for their future children.
• Pregnant women: It can detect potential genetic disorders in the fetus during early pregnancy.
  Individuals with a Family History of Genetic Diseases: If genetic diseases are known in the family, this test can help evaluate the risk.
• Anyone interested in their genetic health: Those who want to understand their genetic health and take preventive measures can benefit from this test.

What do the results mean?

The results of the Next Karyo Full test can indicate whether genetic abnormalities are present or absent. A positive result may suggest the presence of genetic mutations or abnormalities that could increase the risk of certain health problems. A negative result indicates that no known genetic mutations or abnormalities were found in the genes tested.

Prenatal tests available at IntroLab

In addition to the Next Karyo Full test, IntroLab offers a wide range of prenatal tests for early and accurate genetic analysis:

• BASIC Test: Detects trisomies 21, 18, and 13, and determines the baby’s gender.
• PLUS Test: Screens for trisomies 21, 18, and 13, includes sex chromosome analysis, and determines the baby’s gender.
• EXPERT Test: In addition to screening for trisomies and sex chromosomes, this test includes analysis for DiGeorge syndrome and determines the baby’s gender.
• PREMIUM Test: Provides analysis for all trisomies, sex chromosomes, microdeletions, and determines the baby’s gender.
• ALL CHROMOSOMES Test: A comprehensive analysis of all chromosomes, including sex chromosomes, deletions, microdeletions, and gender determination.
• SPECIAL Test: Screens for trisomies, sex chromosomes, microdeletions, 100 hereditary diseases, and determines the baby’s gender.
• SPECIAL + SMA Test: Includes all features of the SPECIAL Test, plus additional analysis for 100 monogenic diseases and spinal muscular atrophy (SMA).
• Next Karyo Plus Test: A detailed analysis of all chromosomes, including sex chromosomes, deletions, microdeletions, gender determination, as well as hereditary and non-hereditary diseases in the baby.

Our prenatal tests use advanced next-generation sequencing (NGS) technology to provide accurate and reliable results.

Specialized genetic panels

In addition to prenatal tests, we offer specialized genetic testing panels:

• Autoinflammatory diseases panel
• Cardiomyopathy panel
• Arrhythmia panel
• Marfan syndrome panel
• Epilepsy panel
• Clinical exome sequencing
• Molecular karyotyping

These panels provide accurate genetic information that is essential for optimal clinical management and treatment.